[Federal Register Volume 64, Number 209 (Friday, October 29, 1999)]
[Notices]
[Pages 58417-58418]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-28304]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control And Prevention
[60Day-00-05]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506 (c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Disease Control and
Prevention is providing opportunity for public comment on proposed data
collection projects. To request more information on the proposed
projects or to obtain a copy of the data collection plans and
instruments, call the CDC Reports Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Projects
1. National Telephone Survey of Chronic Fatigue Syndrome--New--
National Center for Infectious Disease (NCID). In 1997, OMB approved
the information collection ``Chronic Fatigue Syndrome Surveillance and
Related Studies, Prevalence and Incidence of Fatiguing Illness in
Sedgwick County, Kansas'' under OMB Number 09200401. Data from this
cross-sectional, random-digit-dial survey of prolonged fatiguing
illness in Sedgwick County (Wichita), Kansas concluded that prolonged
fatigue affects over 6% of the population, the prevalence of chronic
fatigue syndrome (CFS) was 0.24%, and that CFS prevalence was highest
in white females (0.36%).
The proposed study replicates the Sedgwick County study using
identical methodology and data collection instruments. Beginning with a
random-digit-dial telephone survey to identify fatigued and non-
fatigued individuals followed by a detailed telephone interview to
obtain additional data on participants' health status. Study objectives
are to refine estimates of the magnitude of fatiguing illness and CFS
in the United States, with special consideration of under-served
populations (children and racial/ethnic minorities), and to determine
if the occurrence of fatiguing illness exhibits metropolitan, urban,
and rural differences. Prevalence estimates from this proposed cross-
sectional study of the U.S. population will be compared to those
obtained for Sedgwick County to determine if the Sedgwick County
findings can be generalized to the U.S. The total cost to the
respondent is $0.
----------------------------------------------------------------------------------------------------------------
Number of Average burden/
Respondents Number of responses/ response (in Total burden
respondents respondent hours) hours
----------------------------------------------------------------------------------------------------------------
Screener interview.............................. 51,000 1 0.083 4,233
Telephone interview............................. 12,500 1 0.25 3,125
---------------------------------------------------------------
Total....................................... .............. .............. .............. 7,358
----------------------------------------------------------------------------------------------------------------
[[Page 58418]]
Dated: October 25, 1999.
Nancy Cheal,
Acting Associate Director for Policy, Planning, and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 99-28304 Filed 10-28-99; 8:45 am]
BILLING CODE 4163-18-P
